Skip to main content
    O

    Oscar Health Inc (OSCR)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $31.33
    +0.28 (+0.90%)

    Market Cap: $9.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oscar Health Inc (OSCR) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Oscar Health (OSCR) to earn $2.37 per share in the fiscal year ending Dec 31, 2026, on revenue of $19.06B. Of 11 analysts, 3 rate the stock Buy or Strong Buy, 7 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.64, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 27% of the ratings.

    RatingAnalystsShare
    Strong Buy327.3%
    Buy00.0%
    Hold763.6%
    Sell00.0%
    Strong Sell19.1%
    Consensus
    Hold
    Total analysts
    11

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 3.4% and revenue estimates rise 10.7%.

    Fiscal year ending Dec 31, 2026
    $2.37
    EPS consensus, revenue $19.06B
    Fiscal year ending Dec 31, 2027
    $2.45
    EPS consensus, revenue $21.09B
    Next report
    Feb 8, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.37$1.84 to $2.707$19.06B$18.75B to $19.25B9
    Dec 31, 2027$2.45$2.00 to $3.088$21.09B$16.81B to $23.01B10

    Quarterly Estimates

    The EPS consensus rises from -$1.12 for the quarter ending Dec 31, 2026 to $2.27 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.12-$1.21 to -$1.0314$4.61B$4.39B to $4.81B12
    Mar 31, 2027$2.27$1.81 to $2.764$5.52B$5.04B to $5.85B5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 4 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202721

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 39.4% from $1.70.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.37$1.94$1.91$1.75$1.70+40.0%
    Fiscal year ending Dec 31, 2027$2.45$2.22$2.17$1.88$1.75+39.9%
    Quarter ending Mar 31, 2027$2.27$2.25$2.21$2.21$2.21+2.3%

    Frequently Asked Questions About OSCR

    What is the OSCR stock forecast?

    Consensus analyst estimates put Oscar Health's EPS at $2.37 for the fiscal year ending Dec 31, 2026, on revenue of $19.06B. The consensus rating from 11 analysts is Hold.

    How do analysts rate OSCR stock?

    Of 11 analysts covering Oscar Health, 3 rate it Strong Buy, 0 Buy, 7 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from OSCR next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.37, with estimates from $1.84 to $2.70 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.45, with estimates from $2.00 to $3.08 from 8 analysts.

    What revenue do analysts expect from Oscar Health next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $19.06B, with estimates from $18.75B to $19.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $21.09B, with estimates from $16.81B to $23.01B.

    How many analysts cover OSCR?

    11 analysts rate Oscar Health stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.